Shingles Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Safety and Immunogenicity of CRV-101 Vaccine for the Prevention of Herpes Zoster in Adults Aged 50 Years and Older
Conditions: Herpes Zoster; Shingles Interventions: Biological: CRV-101 Vaccine Antigen High Dose; Biological: CRV-101 Vaccine Antigen Low Dose; Biological: Shingrix Sponsors: Curevo Inc; Mogam Biotechnology Research Institute; Green Cross Corporation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 31, 2022 Category: Research Source Type: clinical trials

Moderna Expands Its mRNA Pipeline With Three New Development Programs
mRNA-1608 is a vaccine candidate against Herpes simplex virus (HSV) mRNA-1468 is a vaccine candidate against varicella-zoster virus (VZV) to reduce the rate of herpes zoster (shingles) mRNA-4359 is a new checkpoint cancer vaccine... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - February 18, 2022 Category: Pharmaceuticals Source Type: clinical trials

Trial to Evaluate the Safety, Tolerability, and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix ® in Healthy Adult Volunteers
Conditions: Shingles; Herpes Zoster; Vaccine-Preventable Diseases Interventions: Biological: Z-1018; Biological: Shingrix Sponsor: Dynavax Technologies Corporation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 18, 2022 Category: Research Source Type: clinical trials